| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Pulmonary Sarcoidosis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Sarcoidosis | |||||
| Sarcoidosis, Pulmonary | |||||
| 3 | More general conditions related to this trial | ||||
| Lung Diseases | |||||
| Lung Diseases, Interstitial | |||||
| Lymphatic Diseases | |||||
| Lymphoproliferative Disorders | |||||
| Respiratory Tract Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| nicotine patch | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Nicotine | |||||
| Nicotine polacrilex | |||||
| 6 | More general drug interventions related to this trial | ||||
| Autonomic Agents | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Stimulants | |||||
| Cholinergic Agents | |||||
| Cholinergic Agonists | |||||
| Ganglionic Stimulants | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Nicotinic Agonists | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Ohio State University | |||||
| American Thoracic Society | |||||
|
